| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 3 | 13 | +0,13 % | ||
| BIOGEN | - | 54 | -0,20 % | ||
| AMGEN | - | 27 | -0,07 % | ||
| INCYTE | - | 25 | -2,28 % | ||
| REGENERON PHARMACEUTICALS | - | 22 | -1,15 % | ||
| MONTE ROSA THERAPEUTICS | - | 21 | 0,00 % | ||
| EYEPOINT | - | 20 | -0,95 % | ||
| NEUROCRINE BIOSCIENCES | - | 17 | -0,35 % | ||
| HARMONY BIOSCIENCES | - | 17 | 0,00 % | ||
| MODERNA | - | 16 | -0,40 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Sa | Samstag-Meldung zu BIONTECH SE ADR - Chance verpassen verboten! | 33 | Maximilian Berger | ||
| Sa | EXKLUSIV zu Biontech: Analysten sehen massives Kurspotenzial - Handeln Sie, bevor es zu spät ist | Hebelschein-Spekulant | |||
| Sa | BioNTech vs. Bioxyne: Wenn Forschungs-Riesen pausieren und Small Caps die Prognosen anheben | Small- & Micro Cap Investment | |||
| Fr | Hedge Fund and Insider Trading News: Warren Buffett, George Soros, Steve Cohen, Ken Griffin, Brevan Howard, Tudor Investment Corp, L.B. Foster (FSTR), Halozyme Therapeutics Inc (HALO), and More | 4 | Insider Monkey | ||
| Fr | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 2 | GlobeNewswire (USA) | ||
| Fr | If You Invested $100 In Amgen Stock 15 Years Ago, You Would Have This Much Today | 5 | Benzinga.com | ||
| Fr | Intellia Therapeutics, Inc.: Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 8 | GlobeNewswire (USA) | ||
| Fr | Syndax Pharmaceuticals, Inc.: Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 2 | GlobeNewswire (USA) | ||
| Fr | Spyre Therapeutics, Inc.: Spyre Therapeutics Announces Grants of Inducement Awards | 2 | GlobeNewswire (USA) | ||
| Fr | Aurinia Pharmaceuticals Inc. - 8-K, Current Report | - | SEC Filings | ||
| Fr | Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM | 33 | Seeking Alpha | ||
| Fr | Alnylam Pharmaceuticals (ALNY) Presents Vutrisiran ATTR-CM Data at ACC.26 | 7 | Insider Monkey | ||
| Fr | RHYTHM PHARMACEUTICALS, INC. - 8-K, Current Report | 3 | SEC Filings | ||
| Fr | Denali Therapeutics Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| Fr | Denali Therapeutics Inc.: Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN) | 99 | GlobeNewswire (Europe) | Denali plans to continue clinical development of DNL593, which is designed to deliver progranulin to the brain using TransportVehicle technologyResults from ongoing Phase 1/2 study in patients with... ► Artikel lesen | |
| Fr | TriNetX arbeitet mit Regeneron zusammen, um Zugang zu anonymisierten elektronischen Patientenakten von 300 Millionen Patienten zu erhalten und damit die Forschung und Produktentwicklung in den Bereichen Biowissenschaften und ... | 109 | PR Newswire | Regeneron hat die exklusive Möglichkeit, umfangreiche Genom- und Proteom-Datensätze mit dem branchenführenden globalen Netzwerk von TriNetX für elektronische Gesundheitsdaten... ► Artikel lesen | |
| Fr | Top Moderna Shareholders | 16 | Investopedia | ||
| Fr | Rhythm Pharma Appoints Kim Popovits To Board; Ed Mathers To Depart | 3 | RTTNews | ||
| Fr | Rhythm Pharmaceuticals beruft Kim Popovits in den Verwaltungsrat | 3 | Investing.com Deutsch | ||
| Fr | Rhythm Pharmaceuticals adds Kim Popovits to board of directors | 1 | Investing.com |